reboxetine has been researched along with Asialia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agren, H; Bodlund, O; Langworth, S | 1 |
| Berzewski, H; Gagiano, CA; Van Moffaert, M | 1 |
| Benedetti, A; Cassano, G; Mastalli, L; Nardi, A; Perugi, G; Savino, M; Versiani, M | 1 |
3 trial(s) available for reboxetine and Asialia
| Article | Year |
|---|---|
Efficacy and tolerability of reboxetine compared with citalopram: a double-blind study in patients with major depressive disorder.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Morpholines; Patient Dropouts; Psychiatric Status Rating Scales; Reboxetine; Sexual Dysfunction, Physiological; Xerostomia | 2006 |
Efficacy and tolerability of reboxetine compared with imipramine in a double-blind study in patients suffering from major depressive offsodes.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Blood Pressure; Depressive Disorder; Double-Blind Method; Electrocardiography; Female; Headache; Humans; Imipramine; Male; Middle Aged; Morpholines; Prospective Studies; Psychiatric Status Rating Scales; Reboxetine; Xerostomia | 1997 |
Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder.
Topics: Adrenergic Uptake Inhibitors; Adult; Agoraphobia; Comorbidity; Constipation; Double-Blind Method; Female; Humans; Male; Morpholines; Norepinephrine; Panic Disorder; Placebos; Psychiatric Status Rating Scales; Reboxetine; Severity of Illness Index; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Xerostomia | 2002 |